NSRXNYSE Israel
Market cap
$40.461 M
$3.46 +1.92%
Close of 7 Aug 2026
Revenue
$1.24B
#1406 by revenue
Earnings
-$5.86M
Loss-making
Shares outstanding
9,015,383
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Nasus Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.